Mitsubishi Tanabe acquires Vaccine maker Medicago

Mitsubishi Tanabe together with Philip Morris Investments BV limited will acquire vaccine maker Medicago for CAD 1.16 per share or CAD179 million.  Post acquisition Medicago will become a joint venture  company of Mitsubishi Tanabe Pharma and Philip Morris Investments. Mitsubishi Tanabe will own 60%, while Philip Morris Investments will own 40%.